Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Longo

Showing results (21-30 of 484) with videos related to

Pageof 49
Sort By:
Seminars in Oncology|February 1, 1993
Chemotherapy drug interactions with biological agentsM Sznol, D L Longo
Progress in Hematology|January 1, 1987
Current therapy for diffuse large-cell lymphomaD L Longo, J Hathorn
Critical Reviews in Oncology/Hematology|September 1, 1992
Hodgkin's diseaseD Kaufman, D L Longo
Israel Journal of Medical Sciences|September 1, 1988
Monoclonal antibodies for cancer therapyR Catane, D L Longo
The Journal of Laboratory and Clinical Medicine|January 1, 1976
Radioassay for serum and red cell folateD L Longo, V Herbert
Immunology Series|January 1, 1989
Lymphokine-activated killer lymphocytes: National Cancer Institute clinical trialsJ Clark, D L Longo
Cancer|October 8, 1997
The biology of aging: the current research agendaW B Ershler, D L Longo
Annals of Internal Medicine|September 1, 1981
The control of chemotherapy-induced emesisL J Seigel, D L Longo
Seminars in Oncology|September 1, 1985
Cytologic, immunologic, and clinical diversity in non-Hodgkin's lymphoma: therapeutic implicationsW J Urba, D L Longo
Cancer Treatment Reviews|June 1, 1986
Concomitant illness in patients treated for Hodgkin's diseaseM A Bookman, D L Longo
Pageof 49

Showing results (21-30 of 484) with videos related to

Sort By:
Pageof 49
Seminars in Oncology|February 1, 1993
Chemotherapy drug interactions with biological agentsM Sznol, D L Longo
Progress in Hematology|January 1, 1987
Current therapy for diffuse large-cell lymphomaD L Longo, J Hathorn
Critical Reviews in Oncology/Hematology|September 1, 1992
Hodgkin's diseaseD Kaufman, D L Longo
Israel Journal of Medical Sciences|September 1, 1988
Monoclonal antibodies for cancer therapyR Catane, D L Longo
The Journal of Laboratory and Clinical Medicine|January 1, 1976
Radioassay for serum and red cell folateD L Longo, V Herbert
Immunology Series|January 1, 1989
Lymphokine-activated killer lymphocytes: National Cancer Institute clinical trialsJ Clark, D L Longo
Cancer|October 8, 1997
The biology of aging: the current research agendaW B Ershler, D L Longo
Annals of Internal Medicine|September 1, 1981
The control of chemotherapy-induced emesisL J Seigel, D L Longo
Seminars in Oncology|September 1, 1985
Cytologic, immunologic, and clinical diversity in non-Hodgkin's lymphoma: therapeutic implicationsW J Urba, D L Longo
Cancer Treatment Reviews|June 1, 1986
Concomitant illness in patients treated for Hodgkin's diseaseM A Bookman, D L Longo
Pageof 49